NewportNativeMD | Newport Beach, CA

Research site

(Unclaimed)

Location

1501 Superior Ave Suite 202, Newport Beach, California, United States of America

Site insights

Top conditions

Top treatments

Treprostinil

Dupilumab

Testosterone

Rocatinlimab

Deupirfenidone

Pirfenidone

Verekitug

Zofin

Brensocatib

NOC-110

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

9 of 15 total trials

Locations recently updated

A Phase 2, Dose Ranging Study Assessing Rocatinlimab in Moderate-to-severe Asthma

The primary objective of this study is to describe the efficacy of rocatinlimab in reducing asthma exacerbations.

Enrolling

Asthma

Drug: Placebo

Drug: Rocatinlimab

A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Participants with Chronic Rhinosinusitis with Nasal Polyps (VIBRANT)

The primary purpose of this study is to assess the effect of verekitug (UPB-101) on the endoscopically determined size and extend of nasal polyps in...

Invitation-only

Chronic Rhinosinusitis with Nasal Polyps

Drug: Placebo

Drug: Verekitug (UPB-101)

Extension Study of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis (TETON-OLE)

Study RIN-PF-302 is designed to evaluate the long-term safety and tolerability of inhaled treprostinil in subjects with idiopathic pulmonary fibrosis.

Invitation-only

Idiopathic Pulmonary Fibrosis

Interstitial Lung Disease

Device: Treprostinil Ultrasonic Nebulizer

Drug: Inhaled Treprostinil

LYT-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF) (ELEVATE)

This study a randomized, double-blind, four arm study to evaluate the safety and efficacy of LYT-100 compared to pirfenidone or placebo in adults wit...

Active, not recruiting

Idiopathic Pulmonary Fibrosis

Drug: Deupirfenidone

Drug: Placebo

Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontrolled Eosinophilic Asthma Patients Treated With Medium-dose ICS-LABA Compared to Conventional Escalation to High-dose ICS-LABA Treatment (BRISOTE)

This study evaluates the efficacy and safety of benralizumab as an add-on therapy in uncontrolled eosinophilic asthma participants treated with mediu...

Begins enrollment in 2 months

Eosinophilic Asthma

Combination Product: Placebo for Benralizumab

Combination Product: benralizumab

Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Adult Patients With Uncontrolled Moderate to Severe Asthma (ATLAS)

This is an interventional, randomized, parallel group, treatment, Phase 3b/4, double blind, 2-arm study to assess the effect of dupilumab compared to...

Enrolling

Asthma

Drug: Placebo

Drug: Dupilumab

Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis (TETON)

Study RIN-PF-301 is designed to evaluate the superiority of inhaled treprostinil against placebo for the change in absolute forced vital capacity (FV...

Enrolling

Idiopathic Pulmonary Fibrosis

Interstitial Lung Disease

Drug: Inhaled Treprostinil

Drug: Placebo

Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

Study RIN-PF-305 is designed to evaluate the safety and efficacy of inhaled treprostinil in subjects with progressive pulmonary fibrosis (PPF) over a...

Enrolling

Progressive Pulmonary Fibrosis

Interstitial Lung Disease

Device: Treprostinil Ultrasonic Nebulizer

Drug: Placebo

Study to Assess the Efficacy, Safety, and Tolerability of NOC-110 in Adults With Refractory or Unexplained Chronic Cough (ASPIRE)

This is a phase 2b, randomized, double-blind, placebo-controlled study investigating the efficacy, safety, and tolerability of Taplucainium Inhalatio...

Enrolling

Refractory or Unexplained Chronic Cough

Drug: NOC-110

Other: Placebo